Aurinia Pharmaceuticals | 8-K: Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS ® Growth and AUR200 Development
Aurinia Pharmaceuticals | 8-K: Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS ® Growth and AUR200 Development
Aurinia Pharmaceuticals | 8-K:Aurinia Pharmicals 公佈了 2024 年第三季度和九個月的財務和經營業績,宣佈進行戰略重組,以進一步關注 LUPKYNIS® 的持續增長和 AUR200 的發展